Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Balance Sheet
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's total assets for Q3 2025 were ¥17.13B, a decrease of -0.63% from the previous quarter. HK:9989 total liabilities were ¥4.70B for the fiscal quarter, a -6.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.